Trial site
Meihekou Central Hospital
- 11running trials
- 6closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Stroke5 trials
- Irritable bowel syndrome3 trials
- Colorectal cancer2 trials
- Crohn's disease2 trials
- Ulcerative colitis2 trials
- Childhood cancers1 trial
- COPD1 trial
- Lupus (SLE)1 trial
- Psoriasis1 trial
- Phase
- Phase 28 trials
- Phase 36 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Completed6 trials
- Not yet recruiting5 trials
- Recruiting4 trials
- Active, not recruiting2 trials
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.3 trials
- Eli Lilly and Company3 trials
- Beijing Tiantan Hospital2 trials
- Biocells (Beijing) Biotech Co.,Ltd1 trial
- and 5 more
Running trials
Recruiting
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
Not yet recruiting
Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
Recruiting
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Active, not recruiting
Not yet recruiting
Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Irritable bowel syndrome3 recruiting
- Crohn's disease2 recruiting
- Stroke2 recruiting
- Ulcerative colitis2 recruiting
- Lupus (SLE)1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026